Back
China Resources Power Holdings Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
36
CRPJY
China Resources Power Holdings
Last Price:
$33.00
Seasonality Move:
0.42%
Sell
38
SRPT
Sarepta Therapeutics
Last Price:
$105.55
Seasonality Move:
5.14%
Sell
36
China Resources Power Holdings (CRPJY)
is a Sell
Is China Resources Power Holdings a Buy, Sell or Hold?
-
The current China Resources Power Holdings [CRPJY] share price is $33.00. The Score for CRPJY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
CRPJY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $106.12. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRPJY Stock Price Chart
What is China Resources Power Holdings's stock price today?
-
The China Resources Power Holdings share price today is $33.00The current trend is relatively stagnant and CRPJY is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $106.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
CRPJY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 41.56 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.14 - 33.34) | Buy |
Bollinger Bands (100): | (33.26 - 38.74) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.32 | Sell |
Relative Strength Index (14 RSI): | 35.13 | Sell |
Chaikin Money Flow: | -665542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (109.06 - 117.26) | Sell |
Bollinger Bands (100): | (113.14 - 127.52) | Sell |
CRPJY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33 | Sell |
20-day SMA: | 33 | Sell |
50-day SMA: | 34.18 | Sell |
200-day SMA: | 37.65 | Sell |
8-day EMA: | 33 | Buy |
20-day EMA: | 33.1 | Sell |
50-day EMA: | 34.03 | Sell |
200-day EMA: | 35.93 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 107.99 | Sell |
20-day SMA: | 112.1 | Sell |
50-day SMA: | 118.2 | Sell |
200-day SMA: | 128.11 | Sell |
8-day EMA: | 108.31 | Sell |
20-day EMA: | 111.56 | Sell |
50-day EMA: | 116.18 | Sell |
200-day EMA: | 122.74 | Sell |
China Resources Power Holdings Earnings Growth & CRPJY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
China Resources Power Holdings Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |